Pachiappan Arjunan,Xianchai Lin,Zhongshu Tang,Yuxiang Du,Anil Kumar,Lixian Liu,Xiangke Yin,Lijuan Huang,Wei Chen,Qishan Chen,Zhimin Ye,Shasha Wang,Haiqing Kuang,Linbin Zhou,Kai Xu,Xue Chen,Haitao Zeng,Weisi Lu,Yihai Cao,Yizhi Liu,Chen Zhao,Xuri Li

Abstract:VEGF-B was discovered a long time ago. However, unlike VEGF-A, whose function has been extensively studied, the function of VEGF-B and the mechanisms involved still remain poorly understood. Notwithstanding, drugs that inhibit VEGF-B and other VEGF family members have been used to treat patients with neovascular diseases. It is therefore critical to have a better understanding of VEGF-B function and the underlying mechanisms. Here, using comprehensive methods and models, we have identified VEGF-B as a potent antioxidant. Loss of Vegf-b by gene deletion leads to retinal degeneration in mice, and treatment with VEGF-B rescues retinal cells from death in a retinitis pigmentosa model. Mechanistically, we demonstrate that VEGF-B up-regulates numerous key antioxidative genes, particularly, Gpx1 Loss of Gpx1 activity largely diminished the antioxidative effect of VEGF-B, demonstrating that Gpx1 is at least one of the critical downstream effectors of VEGF-B. In addition, we found that the antioxidant function of VEGF-B is mediated mainly by VEGFR1. Given that oxidative stress is a crucial factor in numerous human diseases, VEGF-B may have therapeutic value for the treatment of such diseases.

VEGF-B is a potent antioxidant